SBI Securities’s Eloxx Pharmaceuticals ELOX Stock Holding History

SBI Securities’s Portfolio ELOX Stock Details ELOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$31	Hold	2	–	–	﹤0.01%	3850
2026 Q2	$28	Buy	+2	New	+$26	﹤0.01%	3783

Other funds holding ELOX

Pioneer Family Office North Miami Beach, Florida $198M AUM 23.66% 1-Year Est. Return

Old Point Trust & Financial Services N A Newport News, Virginia $341M AUM 20.44% 1-Year Est. Return

Activest Wealth Management Aventure, Florida $540M AUM 34.92% 1-Year Est. Return

SBI Securities's ELOX Position: Q3 2026 in Review

SBI Securities held its Eloxx Pharmaceuticals (ELOX) position steady in Q3 2026 at 2 shares worth $31. The position accounts for ﹤0.01% of the portfolio, ranked #3850.

SBI Securities first reported a position in ELOX in Q2 2026 and has held it in 2 quarters since. 4 funds tracked by Wall St. Rank hold ELOX as of Q3 2026.

SBI Securities held 2 shares of Eloxx Pharmaceuticals worth $31 as of Q3 2026.
SBI Securities left its Eloxx Pharmaceuticals share count unchanged in Q3 2026.
Eloxx Pharmaceuticals made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #3850 holding.
SBI Securities first reported a position in Eloxx Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
4 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.